<SEC-DOCUMENT>0001193125-11-261207.txt : 20110930
<SEC-HEADER>0001193125-11-261207.hdr.sgml : 20110930
<ACCEPTANCE-DATETIME>20110930142723
ACCESSION NUMBER:		0001193125-11-261207
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20110930
FILED AS OF DATE:		20110930
DATE AS OF CHANGE:		20110930

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Concord Medical Services Holdings Ltd
		CENTRAL INDEX KEY:			0001472072
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34563
		FILM NUMBER:		111116618

	BUSINESS ADDRESS:	
		STREET 1:		ROOM 2001-2002, 20TH FLOOR, TOWER A
		STREET 2:		GLOBAL TRADE CTR, 36 NORTH THIRD RING RD
		CITY:			DONGCHENG DISTRICT, BEIJING
		STATE:			F4
		ZIP:			100013
		BUSINESS PHONE:		(86)10-5825-6867

	MAIL ADDRESS:	
		STREET 1:		ROOM 2001-2002, 20TH FLOOR, TOWER A
		STREET 2:		GLOBAL TRADE CTR, 36 NORTH THIRD RING RD
		CITY:			DONGCHENG DISTRICT, BEIJING
		STATE:			F4
		ZIP:			100013
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d237463d6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 6-k</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>WASHINGTON D.C. 20549 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>FORM 6-K
</B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>REPORT OF FOREIGN PRIVATE ISSUER </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>PURSUANT TO RULE 13a-16 OR 15d-16 OF </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>THE SECURITIES EXCHANGE ACT OF 1934
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>For the month of September 2011 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Commission File Number: 001-34563 </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="6"><B>CONCORD
MEDICAL SERVICES HOLDINGS LIMITED </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>18/F, Tower A, Global Trade Center </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>36 North Third Ring Road East, Dongcheng District </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Beijing 100013
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>People&#146;s Republic of China </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>(Address of principal executive offices) </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:1pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark whether
the registrant files or will file annual reports under cover Form 20-F or Form 40-F. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form&nbsp;20-F&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form&nbsp;40-F&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation&nbsp;S-T Rule&nbsp;101(b)(1):&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation&nbsp;S-T
Rule&nbsp;101(b)(7):&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Indicate by check mark whether by furnishing the
information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule&nbsp;12g3-2(b) under the Securities Exchange Act of 1934. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yes&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">If &#147;Yes&#148; is marked, indicate below the file number assigned to the
registrant in connection with Rule&nbsp;12g3-2(b): <U>N/A</U></FONT></P> <P STYLE="font-size:8px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><U><A NAME="toc"></A>TABLE OF CONTENTS </U></B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx226072_1">SIGNATURE</A></FONT></P></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A HREF="#tx226072_2">EX-99.1 </A></FONT></P></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">TABLE OF CONTENTS </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Exhibit&nbsp;99.1 &#150; Press release </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><A NAME="tx226072_1"></A>SIGNATURE </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">CONCORD MEDICAL SERVICES HOLDINGS LIMITED</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">/s/ Jianyu Yang</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Name:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jianyu Yang</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director, Chief Executive Officer and President</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date: September 30, 2011 </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d237463dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><A NAME="tx226072_2"></A>Exhibit 99.1 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="right">


<IMG SRC="g237463g27k53.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Concord Medical Services Announces Share Repurchase Program </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">BEIJING, China, September&nbsp;30, 2011 &#151; Concord Medical Services Holdings Limited (&#147;Concord Medical&#148; or the &#147;Company&#148;) (NYSE:
CCM), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that its board of directors approved a share repurchase program, effective immediately. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the program, and subject to applicable United States federal securities laws, Concord Medical is authorized to repurchase up to $20 million of its
outstanding American depositary shares (&#147;ADSs&#148;) from time to time, depending on market conditions and other factors. The share repurchase program will be funded with the Company&#146;s available working capital. As of June&nbsp;30, 2011,
the Company had approximately 47.5&nbsp;million ADSs outstanding, and cash of approximately RMB417.9 million, or $64.7 million. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>About
Concord Medical </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Concord Medical Services Holdings Limited operates the largest network of radiotherapy and diagnostic imaging centers in
China, measured by revenues and the number of centers in operation. As of June&nbsp;30, 2011, the Company operated a network of 125 centers with 68 hospital partners that spanned 46 cities and 24 provinces and administrative regions in China. Under
long-term arrangements with top-tier hospitals in China, Concord Medical provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The
Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. For more information, please see http://ir.concordmedical.com. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Safe harbor statement </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">This news release
may contain &#147;forward-looking&#148; statements within the meaning of Section&nbsp;21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking
statements can be identified by terminology such as &#147;anticipate,&#148; &#147;believe,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;forecast,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;plan,&#148; &#147;project,&#148;
&#147;predict,&#148; &#147;should,&#148; and &#147;will&#148; and similar expressions. These forward looking </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">- 1 -
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right">


<IMG SRC="g237463g27k53.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
statements are based upon management&#146;s current views and expectations with respect to future events and are not a guarantee of future performance. Furthermore, these statements are, by their
nature, subject to a number of risks and uncertainties that could cause actual performance and results to differ materially from those discussed in the forward-looking statements as a result of a number of factors. Such factors include the number of
new radiotherapy and diagnostic imaging centers opened; the increase in the number of patients in existing centers; the establishment of specialty cancer hospitals; changes in the healthcare industry in China, including changes in the healthcare
policies and regulations of the PRC government; technological or therapeutic changes affecting the field of cancer treatment and diagnostic imaging; and possible effects on consumers and hospitals, hospital construction, and suppliers, as a result
of inflation and the Chinese government&#146;s policies and actions to control inflation. Further information regarding these and other risks is included in the Company&#146;s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
The Company does not assume any obligation to update any forward-looking statement, except as required by law. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>For more information,
please contact: </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Concord Medical Services </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Tony Tian (Chinese and English) </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">+86 10 5957 5287 </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">tony.tian@concordmedical.com </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Christensen
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Teal Willingham (English and Chinese) </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">+86 131 2179 3446 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">twillingham@christensenir.com </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Kimberly Minarovich (English) </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">+1 212
618 1978 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">kminarovich@christensenir.com </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">SOURCE: Concord Medical Services Holdings Limited </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">ir.concordmedical.com </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">- 2 -
</FONT></P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g237463g27k53.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g237463g27k53.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`/`!,`P$1``(1`0,1`?_$`+\```(#`0$`````````
M``````@)!@<*!00!``(#`0$!`0````````````8'!`4(`PD!`A````4"`P8%
M`04%`PT!`````0(#!`4&!Q$2"``3%!46"2$Q(A<8&4%A,D(C43,D)29Q0R>!
MD;%28E-C-(0V1F>7*1$``0(#!`8&!0D$!PD``````0(#$00%`"$2!C%!$Q05
M!U$B,A87"&%Q@9$SH;'!T4)2(R08X6*"-/#QDJ)C1&2RTE.#DY0F-B?_V@`,
M`P$``A$#$0`_`'F=T;N>ZC=-.HQ&RUCW5'T]$0-'0515!+5!3*%12$O(U&51
M=!FU.],=HQ;,6J0#@"8J*G/AB`8;,;*N592IRB9V>05-*CH44Z"1J]5L1>8?
MS`YIR#7W<N93F&F)UO9B*V6W;UMH7]L'[UN%8^^_>NU"VSIV[-MG]D)*C*J3
M?*PSQY#4=$O3%C9%U$NBO&3MNHHDMQ3$X@```91#;[.2N3I&?W=YE>"/_$7]
M=H65LR^9_->6DUF0J4KB6(@[E+7^S9V.+3'*=TUA655R>K5W:DML8^W=1NX<
M*2:4US<*V;`FZBSK\J;$6.Q2:MU@,4<"&$P8AB`;4U:5E7;-LTEI:"M0$2M2
MOG-G%R]?YVIEWIG/LXPZVTVI75EV6]"21V$C7"R&G?>LU_$5>(HUO;H!;O7[
M9,XVSI\P'!LZ632*!Q(!1.*:8`;$I<,<=CI[)^7C),+8:7O"P,7XBK_9&V,7
M_-3SCD9V<WJ?ES)LSI;3^4E[D`FZ.")T:3?;5EI0OVSU*6`ME>.->-3K5=33
M16=:MB)E)&50QQCZDC!2#$R1FDP@H4I1'\.40\!`15%:D54^H.RR`0A+I2`;
M[@2-)MZ-<N<V=]<DR%>"T*G'4IVI`@,4(GJBX7]%E8=UON1W=TLU_;BUEAIZ
MFXVJ7<'(U77KB=I^-J))NP?'(TI:*2;.RF,W76,DX<JF)@;=$(`#ZAV*<IY?
MDZF^.((*Y<G4HI^:V>?,ASKS1R^J[%+R;--,N$I#@4RVZ8F%W7!A=T=-JI[;
M/<LU4ZC+LW1@;P3E(R].478^KJ^81$72D-3S@T_!.XXK0RTDQ`S@K8Z:RA#D
M.`E#-CAB`;7^;,JT.GEM--;6@J<0F]:E=I0!TFPGR*Y_9\SC.UJ5S7,M/&2E
M'G&L+#34%(:*Q'`!BO&NP'1W>?[@%7U;'PD'5-M8QS5]5-(.GH4ENX,R4<M.
MRA(R(CS2$FJJ=PFW5=)@994X&.)1-@!1#:PF\F4&04T9AE90M()ZZOKLJF_,
MKSHJ5>EJ?3:C+!AV84A0W27-P5`7E$1=9GQ7/?M$A<CBP"PX>*@MJ'2Q^_="
MQ$0$0^_PV&5#(Z3`LN?]1?UVT#(N^:)]K:.U"5O_`-)+?[EB]WW<S^&6\S6P
M^9G7F&.[IWHOH3J/##)P_*./Z<_V,^\^W':EAESC?PU<(V?9Q*CBPZ<48Z=4
M;,K%SE\,([TUXA[Y\78,X=AM=&RP[..SNC",;]-L]G>W'#7G4V/CFMW;8?[,
M(USCLSLAK+M"0P+L(7\JE&V&?-JS+JYGSDP$D/-KEHGI_+LPA;0?V@AWW;_L
M;AX9"5F'JQQ_[VG_`/5$/V[*C-K">+N)!T6WAY?9MV9Y92+B`$B!$#Z+,(K0
MPA1E6*``#DIJ=-@;$0$"QCH1#_*`;4,BP@3;2E1*@L0]]FM7]N:+-ALI'Y=S
M5^Z;8')6R#I72PQU%1J2[ENQOY6=J*N2*7.@R2<,6DY2<P;Q`42`N#ALL;\V
M<@;/B5GFTS<K+N7B`MY#SF1EU/(E6S+B2!+SZB4P.)7:T$7#1KLZ+L4:CXV"
MC[P:>JKE2M&$7Q%WJ05?N$R)E8&13:5R@R.(E,#=J=N@],40`2E.<^&&U%S%
MH:F:BF9:@0Z8@`&[$8B/JMHGRDY^;D\N/T2HNF`<6^@1["+U!!CK2DWG1==9
M+VJ:[DWJ@U27/K^/,YE'5=UZX@J(8I@+@`@VLDC3=)1\>8`'*5TV,DH&`88K
M&-Y8[%%,DVZ/0FIM<`0`(:]&F)NMFOFE69[F#SD<EY9S\)=02$@]:```A=ZM
M5FT:#K)>R6N?4W9.+%9]*4UI'D(5V0!%1Q+U=-05*OY,A?$<5!EGJA$@+X&(
M`?;L+YFGP_+-3#?84XVH$Z``H&VBN3N3N"YKKU(4F,XY(/MQ`@`I3"A`@WZ;
M)$I!O)6]NC2SZK*<J".4HJX].R-11CVGY$DHP0@ZA9O)%N5DN@E_&&1:*92F
M,43`4!+Y['=1JU,GZ8RLW*0B!O%]ULR4>C9JRUS`0S,TR:<EI:94HK``2H8H
MW8M%PMJR6[Z.CQOO$E:;O4FX0`GZ*U%LVAU-^=1-L*97,TF;*X,B(E'###Q^
MS9/2N1:K-LJF&@(=$#]=O1+]4>2:1/\`!:@VXTZ`.LI:`-'1<;&M\]]/GQ.^
M8'.9WVJQX;A^6&ZNY]S3DW2W)=YFY_S3]+<Y\/S9LOCM0<"G>(\+P'>81A?H
MA'UV8GC)D_N/XA[8<`WG8XHB&TVFSPQT=JZV97O<>.O2I`#Q'V[MN&`>8B,:
MY`,`\QQ'9O\`+UM8I"5D'`0N_5VE6\]/-E,,>)]18QIVY5+=6-_\NSJMH-[/
MIBE[?]DBB8H'`M9#EQ#,'];3X>7GXB&RMS>I*:RXI1@DVW3Y<B/#"2:B-H`J
M(UB_HLPFMC`6BJN\O"EYW$/[8IU_IV'I1QM4TVD*$2L?/9Q5YPL4.<>`B4RS
MA_NFV<KMO6(C]2/;9U46??))B[JB[E=!3RZJ9#@TJ6,CXA_`.2"8,4Q2E&I"
MF.7Q`AC!]VQW4IY<K495XF"0(1]UL9<ILJMYOY3U^EN((G5SBE8(=:XJ@8:;
M[X6SV4_4U;VMJ6=4@Y)U3-2MHZIZ(EW2:2I'9&LR@ZINJ(I=%04E2F$B2J)O
MNP'9OM.LUEIM3X"DI0('U"XVP9,<=R/FR8D:>'DRJ7G$1`(``44WFS&^T!IZ
M2O;JRA:IF&AUZ/L4R0N)*IBCBBYJ$I%V-(,CX%,F8%Y`%5SI?9PH"'EL)\P:
MIL*6W+2IT&$!Z^CT6??ECR`[FSFMQ>HH4N3:67%+(ZH(3$`DW1)A9L>FDJ0]
M[#5Z0N&4;5-BB`>(X$3H?P\<1S%PP'[?V[!M4)?R8EV/XB5('JOMIW(BS+^8
M.N2.S5N!"L"H=56%N)"3H,-!A9Y2E+4TX=+.G4%$.5W&&^<.(EF9PH)3&.7.
MN9$3GRF,(AB(X"([+Q57FD)#>(P'I/S6U-,4G+TX/Q)-K:_>P"/OA;'7WL(]
MC&ZWI)LQ:(LVH6NH4Y6C)%-!,Q5"R8JD*1,I2AO%1QSB&/I\\-GAD&H5&8D2
MA3J=GZ3;R^\VN7Z%3,^I,I)NMM+0F*DI(1&`Z+K7%^M]!3'?K;_Y(9-]@._S
M>Z?#Y-YY[S\F?]NT'"KQ!^(WBV$<4>KV(PCTV)>&R?Z,=UZ^[<<Q>G^;L>?<
MA[4]T=6M_D[T6MKVBX-5Y2T'3<_!5@G+ME`4A"F3:R$5(QS5XF8BC542G3,!
M#`8,0$=J++F;!1Y%$JY'9B.CTJ)^FSYYV^7S-',"OO9BH#\HE3H;@%]L%MM*
M+_:F(]%HA:C0_P!V>QU!0%M;5ZH;/TO1=-I/$(>$Y8H^(T1>/5I!?,Z?4PX<
MKJG>.%#B8QO(V&WYFJW0)F85,OL[52H:1H]-JG+'+#S#Y>IR:;)5&4981H`4
M;3UYIQ[T3]H[8/\`5U:!PR>-G#1RF%/H`4S=TD=%P0V[I,JQP.F<0#*)3%'Q
M#;D*MEL7IE0A7WH:/3:^=R5YA7&U(J54EW9`@AQ"5'$I!$"!Z38K>VEI#N/H
M^LY65`7*FJ9G)B?N+)5FU<TJ:0-&E0?,F2!S*<R;MERO%';8ZAR@`D`!``VI
MLW5:3G'6-SU7>VZS$Y(9%JV2Z=/,U:`5,JB-8U_79;&KKLNW4NQJ)N1=*S=5
MV]@:)KZ3ZG7@*C/.(/8^IGR"03Q&R,>P7019R$BAQ0"4V`BH8,`Q\22EYN3+
MRR6%F!2D#W76SCS7\K%9S)75U6@O867GU.*$80QJ*B/9&%F6=M?1#):+[/5#
M3]9/Z=J&Y58U.M-534%-I/$XU2/9I)M8.+:`^20>"@R0WIQ`P``JJB/CL,UV
MM/5.:3@[`!^4VT7R*Y4M<M:.ZAY6*HO$1/1!&&'OOL)5T=".N5AK)N_J@TQW
MAM50"ES&+&$0"HXR1E'Q(9LQATW+=\@M$O&2#@SR*W@&3Q$P'^[$2"5K5-:H
MZI&<;VABDX2+KCILLZ[RNYGR',1W,F4G&VGGBX4J6>K!22%1]8^6TA/8SO7X
M@`:L[##CX"/2`>'^>ES".U*_5:,D]642!:X.7O,B=,[)^^P:7O[1FOW436B]
MQ;NWALI4]:+Q#"$-)H)3<*B:/BA4&/2*U84\5`ADC+'SC^<##Y;&%/SY3J9+
M%B5EP/=9)YO\K7,'/593/YAJ14F(B2J/TZK']],F<^FG\+^NHSKWGO6_5?!O
M^F>M.HN?\/PV?CN0?W.?\7]YE^S87[U'O#QW97X,.'V0C9\?I_1X*>%&]?YO
M;[3T[7:8?HL25\^XMI>L!<R:M;<:H*R8UE"(QB\BA#6]JFHF")):,;R;,.8Q
MC!=FH)F:Y#"!38E$1#S#:FEJ5,3C*5H2"DQUGI]1LPLQ<T<E98KK]-J[<TJ?
M9PXRA,4]9"5"!Q#[)'ML+54][G2-"3$%#T_#7<K<\JL*+Q6+HES&C#`*@`59
MTRF3-'CA'A,5\R!%`W8>>(AM8M97G4(6M*<(@.G]EEW->9KEJS4V)0,5):5*
M(@AH.`7#2"NX>K2;683O!:)C*H-RU)<45G*Z#5,@6FK@I=ZY5313P5&*RE+G
M5#$PB`88CCM7&BS8;<6[B4TD$D'HZ(:[$$CSZR!4)TRTI+U-+ZH!(V`2(^@A
M41Z[75JHUO4GI58T))3UK[MW':5ZA,N6*UM:9YR$2VA6D<\57GA%9/A$G*#\
MHIF-YY#_`+-OLM0S4W$L(*0H"[7#U=%BK-_-2D98D69Y^5GULK$1`0$(1OOO
ML*]K>\?9:[M6T?3%)V:OVY2JZJ(FE4ZF0IMC)T_!2,TY;MDEJ@D8U\Z;QZ#;
M?E,MO1*8J?CAM8S64IF04EM;EYAK(]YC9;T+S.Y8KU0=3)TZH"6EUJ0L@=7$
MDP,1&&G6;0I?O@V=0<566)T_:@:CBZ,F9.$J"HH:%BGL+'JQ#I=FX=/7Z+TR
M#)F(-]X!EQ)Z#!CXXX2WLG3+2VDEU.)Q&(`1T1UWWFT68\S^66IJ:4Q2Z@Y+
M,`N+4`()";NF[IL8D%KVMG,Z.Y'6L2F:O96ZCD7J[JFMW'&JLXL*E)3(IIIE
M=IQQC+/3E,`BJ`91\]JB9I<P)Y-.4?Q($Q]A.OU694KS:H%:Y>CF++R]07(+
MN2T"8DA6&X1AIMSZ&[FFDRI[8V^N16%QF%I$+CQ\Q)TW`W%6)'SJK&&F7-/N
M7*X,>-9D)S-D<F.]_$(!Y[?5Y<GD+ZA4I'K'TFU=EWG=DRL9?=K=0=:ITPT2
M`U,0"C#6!"^-JDJ'O&Z/XBY:UO6M12<[%MZ:>5"E<B)69JT,\=M(B0DR4VD\
M,N5[SMRNP!J4@HY`66+B8"B([64ODZM3J2MM`".D?U6$*SYG>6#;G6F7<0U"
M(!]A]-UIS]3BUGPM^:7MU<#HGKCHCI#&%ZMYGU!T_P`5AQG+.'XOU8;S')M7
M]W*AQ3@^+\W@Q:=4(PC8L\;\I^&WB3LU\"WK80A?CVFSC"&C%?947=+NVXMC
MJJK5-]6>I&`;RD72QXAC;R[%"0])+J(4G'YU$Z9?-',W&))KB)ES+B7>GSG)
MX&#8[RBVT::TIX7=:_\`B-LG^8?.-1IW,N=H]$2'9D[`.!0$$%3#9$"!$Q!!
MO.NP$V-L;J9KEVVOM-4/J9FI6MF)5:(N%0]:4=3-4S3-<YHUR[</:W*M-/-\
MBD5-L=N4A=R)2EQ`0#8J>J\@`99*4^NRTHN3,Z;ZJJ3Y4E\("TM@EO$#'LX8
M*4?08PM+*0NA5]47&5MS%UCKC4K:#EV[*7IV:O7:N"D8]>.E4FSEL\1FX6,*
MX49D3-O$4E#*K!B!0$1VK)MM!I[ZFDI)+9A:7ERMUIS.#<O+N3#4XAY(*75K
MAIU)48*]1!%M"NNRKM3,!3MJJ:T_UY9VE)2JX2K&E2PEVGK`E2U9R^#C#MFM
M%)+$.+V68I'=B[W089CD'[0V`,KRK4S/N.S!6V&S<$B(TZXZ!;9G.2J9BE,E
MR3<JXP7G405C"(WI@87:=-DH=KBX&HJC8^)AZ)N)8R@[.UE?=K"UC`7.7:M:
M^JJ9Y=!!.1M"G5#>+R"\>LB1$O@(JJE'S'8IKLJ)QUN:+CG5%T!&(_;;-7)B
MHYDDY:>I$T9=+4]/36)9"<:<"W(88C6+C'1&UA:*C&2T1]UH#@81+(5P02'S
M92B$34!\R(^8`L<,PB4PYL<<=N%2*U5>G@J/4;@/>J_Y86)N7LV\CEIG-ZHJ
M0L*4ZR',*<2$@%(A=`G[4#=&^UAVTD[SP?9CH2IK4L;6RE,TLK<*9NM3USH-
M.IH:<HIE44HJ6/8Q+I)=N[?)2X(K8',7'(`>>T*;2E6:T)4=+9B?X##WV_>7
M:EFJ0\LDK,4"94Y+24WB*E)1%Q&\`X%##"%Y!(ZT#8(J]JYM6E1=O2N)BQ-)
MW/))VFKN0E;"6]ITE-4W5Q$JZJI)PQC(*-2,1D@V(V*[=90,)#)"IE$=KO=R
M$+25J2-2KB1<+[[C[;+3,DU3,S5^AU<TR7G9J9`#LJ5.(9.%4(_AE*HF^-O/
M>L]AZE@-*6K2B=.%,6@MC*7?J.W%U;7HJN9J`GDZ1GXE<SB8-N45U"2,%QF\
M,4"G!-OB.(^`]*1,U0NKI9>6&S'KW8O=`"%HN:U92GVI;.IH4HU+!S"II)<+
M=Q$;R<6BSJ_>G1+\#>JOC[3OQ/\`DI[?=';@_),>O.2>Z7+M_P`3PG./X_<Y
MM[P_JPQ\-@W=)WO+NV\KWS#\2Z,8:/5J]5M;=[.77@;Q[A<MW2V^#=;]GM=I
MAQ=.+'?ITZ[47W6;?:1[;35V=1*U74A(:P5V%#OJ.H&O)%O4\`(P*$/&I%-;
M@B?"JB\@TP5WTAG+B3,7$/#;KEPU1V7P2Z095`,22!KC=?Z]5@3S$TG)E*5/
M56665\P9Z:E5-MX204MI:;(*H84]1$;R+!_J.OO'7XO'VL)]"1CDJ\9P]L'%
MQ*9BVA(<T#+3574RHD@O3;9-(L8A(MBB[9I&P1!OAE+AM=TZ@SA9F:@N&[)-
MQQ`F_P!$8PC8&S_G%$WG?*#]&7#9,!,PWAP8EA(B@C00-((NOMW+<.-*>L?6
M;J7DM7-34E1ZU.7%)#V738"RMA/20TY5<@)23<U$@T)5,BQ)$MR*%DB[XP*8
M`)\<0XE-6EY,)E$!4L1AO5]9C:=1YO*6:^9\S4LZ8J7,2I2MA+:2H.K"OM8`
M1HT@PTQC8]NYZDB34+V[]P`"BG4]VB-CB(''<EHA@1,R:H9@$BB0%'$!\?/:
M'DL!Z9F&W[EW_/9C^9F7-.8H\NP\H-/.[)$+XJ"8W]`@--D5Z:B`HGH],8`.
M<NO)V)3&#,8O\GMQZBB.(AERXX_=]VQ9.L$)2A%Z4@>X"V3J(M^2G&IE;ZTR
MJ:C,I40#$*6I8%POO.NQK:-I:*8Z+NZ3&O9%BT>S$I7@QC9T[;-W#\4XNHD\
M&J*JI%7`@<,/24?'`-H%1E'Q5I)V'5"/DZUFADAVDTGEWFC+T_,'>77%N+!'
MWX%.$Z^J03#1KL45B?3V&JX'T@7V^N@)E!-EPPK!P`F\,!$1$`^_:@GB7,UH
MV?:*(#W']MFGDR2;EO+(Y*L@*D#C45&X_%!T&^P$V+<))7/[7!45T%U4K376
M!T1%9)4Z:IYFY)P(LF4PG34404`<#@43`.QE5$%JGJ41`XA_LI^F-D9EA5/;
MS'0IBDJVCB%*!!$(=>.NU!5)5U<36@RV5EZ6I8TC$)U]>V^U8585J9=>G&%'
MU8--1N98I0!A'+N)$-\<1Q5/E1`,@&-MU;$M+U54T3!"DP']5J"?K-8J>244
MR4DT*D0\HK5$"%\+.XY;8_Z'/'=(1?1WM#U#RO,MF]T>9[KJ'B,>)YKU_P#Q
M>;''#T?@\-@O"YWRT?9C[,,8VT-NF7_TQ;#J[EO4=?QMOHTZ<7LAJM;.H[Z3
M7S`DODYR#Y$<II/C^OO</HS@.7-NEM]C_AWO.&R9,_JWF.;U8[5]*[T<)5PS
M!N,#'X6*$3'M=;I]EF#G3P)\0E]\=X[V8FXXM]V,=FG!AP?@=G#'#]J,;XV@
MUU_I$?,*)ZZYK\DNHK4\HY![Q].<UX*$]L^&Z9_H3@."X3)E_A\O[S\VTV3[
MZ\+>W:'#X=>.RC"_1'K>ZPS5_P!-/?R2W_;]ZL?Y?#O^RQ0'W?P=$.U=;I:N
M_H\>\C+W^Z;]Y>?P7,.@?</F_/.8AR;K3VU_@.(X_P`^8^K_`'GAM'D^]VX_
M@0W75BV<?[U]IF=_TY=YF>\.WX_C&'=]^A&-V/8=2$>FZQ;ZK/AC[BZ9_D3S
M7K;FE8>PG+^ON'X_I]KU+Q72?\LW7)=WDYE^GC^[]6.U;1..[TYPG#O'VHX/
M3]Z[W6/^:7A/LZ5XA[;#O7Y2&\QVN`Z=C?V8_$N]ME_6L^C+NK+>WG5N3Y"K
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MP)Z=_HE>\5O/9#JWW/XJ2Z,XKY#\-Q'*)GF._P"H_P"2Y.7\5CO_`-/>8?GR
M[$-0[[;J-]P;OJ^%]%]D]EC]+G$Y3@.^;]C.QQ<2ABC?''U?[5UC"LO]-?XD
M7)]L\GQYZ?N5USS;W!ZIZ9YF[ZZX7J'^O.5\XWN3A/1Q&&Y]67:LFN]6\HV_
MQ/LPP8?;"[1TV.Z#X`]QWN%?^L05CQ[UM81OAC_&T_=M'_\`\V/IT?\`FWP@
MZH_]U\XYKU5_]$Y-U#_T>7_A[</_`"+C?V>+;+_#AAP_V='MM7__``'P7_SG
5A?Q3_7[3>MO_`-S@VO\`RX?NV__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
